We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Increased HbA1c Identifies Rapid Kidney Function Deterioration in Diabetics

By LabMedica International staff writers
Posted on 13 Nov 2019
Print article
Image: Diabetes and higher HbA1c levels are independently associated with adverse renal outcomes in inpatients following multiple hospital admissions (Photo courtesy of Anitha Anchan).
Image: Diabetes and higher HbA1c levels are independently associated with adverse renal outcomes in inpatients following multiple hospital admissions (Photo courtesy of Anitha Anchan).
Among adults with multiple hospital admissions, those with type 2 diabetes were more likely to have worsening renal function compared with those without diabetes. The association between glycemic status prior to the first hospital presentation with developing adverse renal outcomes overtime in patients with multiple hospital re-admissions has been assessed.

While poor glycemic control defined by higher HbA1c levels is associated with worse renal outcomes, the presence of diabetes independent of glycemic status is also associated with high risk of relatively rapid deterioration in renal function. Therefore, all patients with diabetes, regardless of their glycemic control, are a logical target for structured preventive interventions.

A team of scientists from the University of Melbourne (Melbourne, Australia) conducted a prospective observational cohort study with 4,126 adults aged at least 54 years who made two or more visits to Austin Hospital (Heidelberg, Australia) from 2013 to 2016 (median age, approximately 77 years; 41% women). Participants had estimated glomerular filtration rates of more than 30 mL/min/1.73 m2 and “no prior history of renal replacement therapy” before study onset. The team analyzed data on HbA1c and eGFR from 465 days of median follow-up time.

Diabetes was diagnosed in 26% of the population and the scientists noted that stage 4 chronic kidney disease developed in 19% of those with diabetes and 13% of those without diabetes. Among adults with multiple hospital admissions, those with type 2 diabetes were more likely to have worsening renal function compared with those without diabetes.

An eGFR decrease of more than 50% was more likely to occur for participants with diabetes versus without diabetes. The team also noted a higher predicted adjusted probability for those with diabetes and an eGFR of at least 45 mL/min/1.73 m2 before study onset. A “rapid decline in renal function,” which was characterized by an annual decrease in eGFR of more than 5 mL/min/1.73 m2, was more likely to occur for participants with versus without diabetes particularly between the first and second year of follow-up.

Ending the study at an eGFR of 30 mL/min/1.73 m2 was more likely for participants with diabetes compared with those without diabetes. The scientists noted that HbA1c at study onset did not affect the likelihood of ending at an eGFR of 30 mL/min/1.73 m2, but that it became 7% more likely that a 50% eGFR decrease would occur and 11% more likely that a “rapid decline” would occur with each HbA1c increase of 1% at baseline.

Niloufar Torkamani, MD, PhD, FRACP, an endocrinology/general medicine physician and lead author of the study, said, “We found that the presence of diabetes and higher HbA1c levels were strongly and independently associated with adverse renal outcomes at follow-up. Such patients are at high risk of relatively rapid deterioration in renal function and are a logical target for structured preventive interventions.” The study was published on October 22, 2019 in the Journal of Diabetes and its Complications.

Related Links:
University of Melbourne
Austin Hospital


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.